| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Dec, 2016 | Dec, 2015 | Dec, 2014 |
| Sales | 708,900 | 817,190 | 935,590 | 982,220 | 984,060 |
| Sales Growth | -13.25% | -12.66% | -4.75% | -0.19% | +16.84% |
| Net Income | -51,690 | -64,200 | -41,510 | -299,710 | -147,470 |
| Net Income Growth | +19.49% | -54.66% | +86.15% | -103.23% | -111.73% |
Bioplus Acquisition Corp Cl A (BIOS)
Bioplus Acquisition Corp Cl A (BIOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BioPlus Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. BioPlus Acquisition Corp. is based in New York.
Fiscal Year End Date: 12/31